Skip to main content
Quest Diagnostics

An Alignment Initiative for Prenatal Interpretation of Low-Penetrance ClinGen Recurrent Copy Number Variants

ACMG2026 

American College of Medical Genetics and Genomics

Baltimore, MD, March 10-14, 2026

Poster presentation: An Alignment Initiative for Prenatal Interpretation of Low-Penetrance ClinGen Recurrent Copy Number Variants

Authors: Kantarci, Eno C, Qi Z,  Senaratne N, Schwartz S, Bui P

Medical Specialty: Genetics, Women's health, OB/GYN

Related content 

Audio Podcast
Discovering Prenatal Genetics
Audio Podcast
Insights into successful family planning: A diagnostics perspective
By: Dr. Damian P. "Pat" Alagia III, MD, MS, MBA, FACS, FACOG
Conference Presentation
Case Examples of Classifying Copy Number Variants
Test FAQ
QNatal Advanced
Test FAQ
Chromosome Analysis Chorionic Villus Sample
Test FAQ
Chromosome Analysis and AFP with Reflex to AChE Fetal Hgb Amniotic Fluid
On-Demand Webinar
Demystifying the Diagnosis of Polycystic Ovary Syndrome
On-Demand Webinar
The Link Between Reproductive Abnormalities and Cardiometabolic Conditions

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.